You are here: Home
Friday, 06.03.2015

Abstract deadline EXTENDED

Abstracts presented at the 56th Annual Congress of the Scandinavian College of Neuro-Psychopharmacology will be published in 'Acta Neuropsychiatrica'.

EXTENDED deadline for submission is March 15th 2015.

Acceptance on abstracts will be sent in the week starting with March 16th 2015.

56th Annual Congress of the SCNP

We are happy to announce that our 56th Annual Congress will take place in Copenhagen at the Copenhagen University, from April 22nd-24th, 2015.

Program

WEDNESDAY, APRIL 22th, 2015

PRE-MEETING EVENT

13.00-19.00 CINP EDUCATIONAL WORKSHOP: UPDATE ON NEUROPSYCHOPHARMACOLOGY
Brian Leonard (Galway, Ireland) & Gregers Wegener (Aarhus, Denmark) 

 

THURSDAY, APRIL 23th, 2015

09.00- REGISTRATION OPENS

09.00-10.00 SCNP GENERAL ASSEMBLY (FOR MEMBERS ONLY)

10.00-10.05 PRESIDENT´S WELCOME

10.05-10.50  OPENING LECTURE

Novel pharmacological approaches in the treatment of schizophrenia
Wolfgang Fleishchacker (Innsbruck, Austria)

10.50-11.00 STRECHNING LEGS BREAK

11.00-13.00   SYMPOSIUM

Update on new drugs

Vortioxetine – a novel multimodal antidepressant
Connie Sanchez (New York, USA)

Lurasidone – a new drug for the treatment of psychosis.
To be announced

Inhalable Loxapine - Real life experience
Charlotte Emborg (Aarhus, Denmark)

13.00-13.45  LUNCH 

13.45-15.15  SCNP YOUNG SCIENTIST SYMPOSIUM

Speakers to be announced (based on competition)

15.15-15.45  COFFEE BREAK

15.45-16.30 SCNP LECTURE

The implications of recent research for the way we think about psychosis
Sir Robin Murray (London, United Kingdom)

16.30-17.15  SCNP LECTURE

Should prodromes be treated?
Merete Nordentoft (Copenhagen, Denmark)

17.15-18.45 POSTER SESSION. 
Refreshments

18.45-     SCNP 2015 RECEPTION IN POSTER AND EXHIBITION AREA
Standing dinner with food and wine 

 

FRIDAY, APRIL 24th, 2015

09.00-09.45  SCNP LECTURE

Societal consequences of (long-term) psychopharmacological treatments
Paul Lichtenstein (Stockholm, Sweden)

09.45-10.15  COFFEE BREAK

10.15-11.45   SYMPOSIUM

Central Effects of Glucagone Like Peptide-1 (GLP-1) Receptor Stimulation

GLP-1: Central and periferal effects of GLP-1 receptor stimulation
Philip Just Larsen (Frankfurt, Germany)

Cocaine addiction - role of GLP-1
Anders Fink-Jensen (Copenhagen, Denmark)

GLP-1 and alcohol abuse
Emil Egecioglu (Gothenburg, Sweden)

11.45-13.15   SYMPOSIUM 

Recent updates on ADHD

Medication for ADHD and criminality and other consequences
Paul Lichtenstein (Stockholm, Sweden)

Title to be announced
Søren Dalsgaard (Aarhus, Denmark)

ADHD and substance use - the patient´s perspective
Christina Nehlin Gordh (Uppsala, Sweden)

13.15-14.00  LUNCH 

14.00-14.45 SCNP LECTURE

The endocannabinoid system: relevance for psychiatry
Sâmia Joca (São Paulo, Brazil)

14.45-16.15  SYMPOSIUM

Depression: New options in treatment resistance

Ketamine and glutamatergtic modulators
Gregers Wegener (Aarhus, Denamrk)

PEMF - a new treatment option
Erik Roj Larsen (Aarhus, Denmark)

Elevtro Convulsive Therapy - an update 
Martin Balslev Jørgensen (Copenhagen, Denmark)

16.15   CONCLUSION OF THE MEETING